Sweden
· Delayed Price · Currency is SEK Corline Biomedical AB Statistics
Total Valuation
STO:CLBIO has a market cap or net worth of SEK 254.70 million. The enterprise value is 242.97 million.
| Market Cap | 254.70M |
| Enterprise Value | 242.97M |
Important Dates
The last earnings date was Wednesday, April 30, 2025.
| Earnings Date | Apr 30, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
STO:CLBIO has 24.49 million shares outstanding. The number of shares has increased by 4.98% in one year.
| Current Share Class | 24.49M |
| Shares Outstanding | 24.49M |
| Shares Change (YoY) | +4.98% |
| Shares Change (QoQ) | +7.54% |
| Owned by Insiders (%) | 83.26% |
| Owned by Institutions (%) | 13.67% |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 25.84 |
| PS Ratio | 18.38 |
| PB Ratio | 3.04 |
| P/TBV Ratio | 25.03 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -9.88 |
| EV / Sales | 17.53 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.75
| Current Ratio | 2.75 |
| Quick Ratio | 2.53 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -468.41 |
Financial Efficiency
Return on equity (ROE) is -28.03% and return on invested capital (ROIC) is -10.68%.
| Return on Equity (ROE) | -28.03% |
| Return on Assets (ROA) | -9.82% |
| Return on Invested Capital (ROIC) | -10.68% |
| Return on Capital Employed (ROCE) | -17.88% |
| Revenue Per Employee | 1.07M |
| Profits Per Employee | -1.89M |
| Employee Count | 13 |
| Asset Turnover | 0.15 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +0.50% in the last 52 weeks. The beta is 0.20, so STO:CLBIO's price volatility has been lower than the market average.
| Beta (5Y) | 0.20 |
| 52-Week Price Change | +0.50% |
| 50-Day Moving Average | 9.66 |
| 200-Day Moving Average | 9.22 |
| Relative Strength Index (RSI) | 52.83 |
| Average Volume (20 Days) | 13,504 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, STO:CLBIO had revenue of SEK 13.86 million and -24.60 million in losses. Loss per share was -1.09.
| Revenue | 13.86M |
| Gross Profit | 10.25M |
| Operating Income | -14.99M |
| Pretax Income | -24.60M |
| Net Income | -24.60M |
| EBITDA | -14.89M |
| EBIT | -14.99M |
| Loss Per Share | -1.09 |
Balance Sheet
The company has 11.74 million in cash and n/a in debt, giving a net cash position of 11.74 million or 0.48 per share.
| Cash & Cash Equivalents | 11.74M |
| Total Debt | n/a |
| Net Cash | 11.74M |
| Net Cash Per Share | 0.48 |
| Equity (Book Value) | 83.84M |
| Book Value Per Share | 3.42 |
| Working Capital | 10.00M |
Cash Flow
| Operating Cash Flow | -16.72M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 73.97%, with operating and profit margins of -108.15% and -177.48%.
| Gross Margin | 73.97% |
| Operating Margin | -108.15% |
| Pretax Margin | -177.48% |
| Profit Margin | -177.48% |
| EBITDA Margin | -107.45% |
| EBIT Margin | -108.15% |
| FCF Margin | n/a |
Dividends & Yields
STO:CLBIO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.98% |
| Shareholder Yield | -4.98% |
| Earnings Yield | -9.66% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |